The applicant will attempt to determine how exercise enhances and denervation inhibits the ability of insulin to stimulate glucose transport and glycogen synthesis in skeletal muscle. They propose two novel hypotheses. One hypothesis links alterations in the energy expenditure of the muscle cell such as occur during exercise or inactivity, to changes in the concentrations of malonyl CoA and cytosolic long chain fatty acyl CoA (LCFA Co A). They speculate that changes in the concentrations of these metabolites lead to alterations in the activity of one or more PKC isozymes and other events that affect insulin signaling, and its ability to stimulate glycogen synthesis. The second hypothesis focuses on a pool of GLUT-4 glucose transporters, possibly associated with muscle glycogen, that has recently been identified by Dr. Pilch. They propose that transporters from this pool are mobilized predominantly during exercise, but once mobilized can be recruited by insulin. If so, this pool could account for both the enhancement of insulin-stimulated glucose transport after exercise and the decrease in insulin-stimulated glucose transport in denervated and immobilized muscle. These hypotheses will be tested using intact rodents and perfused and incubated rodent muscles as models.
The specific aims are: 1) To characterize the temporal interrelations between changes in malonyl CoA and other metabolites, the distribution and activity of PKC isozymes and insulin signaling and action in denervated (inactive) muscle. They will also study the distribution of GLUT-4 between the exercise-and insulin-recruitable pools in this model. 2) To determine whether prior exercise causes changes in signal transduction and GLUT-4 distribution opposite to those produced by denervation and limb immobilization. 3) To compare the mechanisms by which insulin-stimulated glucose transport and glycogen synthesis are inhibited in denervated muscle and muscle perfused or incubated for many hours with a hyperglycemic medium. These studies should provide insights into the mechanisms by which contractile activity and hyperglycemia alter the action of insulin on muscle. They should also result in the development of appropriate model systems for examining the effects of insulin and other agents on muscle metabolism and signal transduction, in vitro.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK049147-05
Application #
6176607
Study Section
Respiratory and Applied Physiology Study Section (RAP)
Program Officer
Laughlin, Maren R
Project Start
1996-08-01
Project End
2002-03-31
Budget Start
2000-08-01
Budget End
2002-03-31
Support Year
5
Fiscal Year
2000
Total Cost
$314,956
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
LeBrasseur, Nathan K; Kelly, Meghan; Tsao, Tsu-Shuen et al. (2006) Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am J Physiol Endocrinol Metab 291:E175-81
Nawrocki, Andrea R; Rajala, Michael W; Tomas, Eva et al. (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281:2654-60
Kuhl, Jeanette E; Ruderman, Neil B; Musi, Nicolas et al. (2006) Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle. Am J Physiol Endocrinol Metab 290:E1296-303
Suchankova, Gabriela; Tekle, Michael; Saha, Asish K et al. (2005) Dietary polyunsaturated fatty acids enhance hepatic AMP-activated protein kinase activity in rats. Biochem Biophys Res Commun 326:851-8
Hosaka, Toshio; Brooks, Cydney C; Presman, Eleonora et al. (2005) p115 Interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation. Mol Biol Cell 16:2882-90
Yu, X; McCorkle, S; Wang, M et al. (2004) Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia 47:2012-21
Saha, Asish K; Ruderman, Neil B (2003) Malonyl-CoA and AMP-activated protein kinase: an expanding partnership. Mol Cell Biochem 253:65-70
Ruderman, N B; Cacicedo, J M; Itani, S et al. (2003) Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. Biochem Soc Trans 31:202-6
Itani, Samar I; Saha, Asish K; Kurowski, Theodore G et al. (2003) Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase. Diabetes 52:1635-40
Tortorella, Lori L; Lin, Connie B; Pilch, Paul F (2003) ERK6 is expressed in a developmentally regulated manner in rodent skeletal muscle. Biochem Biophys Res Commun 306:163-8

Showing the most recent 10 out of 33 publications